Intrapulmonary Percussive Ventilation Therapy: A Critical Tool for Respiratory Therapists

Sentec IPV® Therapy simultaneously targets secretions, atelectasis, and air trapping, helping respiratory therapists reduce secretion burden and restore the lung capacity needed for effective gas exchange.

A MULTIFACETED APPROACH FOR COMPLEX NEEDS

More than Airway Clearance

Sentec Intrapulmonary Percussive Ventilation (IPV®) Therapy simultaneously targets three common, interconnected challenges in respiratory care — secretions, atelectasis, and air trapping.

Remove Secretions

Mobilize hard-to-reach secretions and move them outward by accessing distal airways and encouraging strong expiratory flow.

Relieve Air Trapping

Access the deepest part of the lungs beyond obstructions and restrictions to relieve air trapping.

Recruit the Lungs

Recruit collapsed alveoli in atelectatic areas of the lungs with a therapy that dynamically responds to airway resistance and compliance.

BACKED BY CLINICAL EVIDENCE

Better Outcomes for Respiratory Patients

Secretions can trigger a cycle of inflammation, infection, and declining lung function that leads to poorer outcomes. IPV® Therapy can help break that cycle, supporting outcomes like reduced infections and hospital stays, backed by proven clinical results.

11× More Secretions Removed compared to oscillation and lung expansion (OLE) therapy in a simulation study.¹

Faster Atelectasis Resolution compared to traditional chest physiotherapy (CPT), with recovery in half the time.²

Shorter hospital stays for COPD patients compared to standard treatment without IPV therapy.³

BACKED BY CLINICAL EVIDENCE

Better Outcomes for Respiratory Patients

Secretions can trigger a cycle of inflammation, infection, and declining lung function that leads to poorer outcomes. IPV® Therapy can help break that cycle, supporting outcomes like reduced infections and hospital stays, backed by proven clinical results.

11× More Secretions Removed compared to oscillation and lung expansion (OLE) therapy in a simulation study.¹

Faster Atelectasis Resolution compared to traditional chest physiotherapy (CPT), with recovery in half the time.²

Shorter hospital stays for COPD patients compared to standard treatment without IPV therapy.³

CHALLENGE THE STATUS QUO OF AIRWAY CLEARANCE

How IPV® Therapy Works

While techniques like chest physiotherapy (CPT) are familiar to ICU teams, evidence for their effectiveness is limited. As a respiratory therapist, you can go beyond the standard to provide more targeted, effective support for secretion clearance with IPV® Therapy.

So how does it work? Each pulse delivered through IPV® Therapy combines four distinct flow characteristics that work together to mobilize secretions and support lung function:

  • High-Velocity flow to reach distal airways
  • Entrainment to support lung recruitment
  • Percussion to break up secretions and mucus plugs
  • Unrestricted expiratory flow to move secretions outward
DESIGNED TO SUPPORT DIVERSE NEEDS

Which of your Patients Could Benefit?

IPV therapy can support a diverse group of patients who have difficulty with secretion clearance, atelectasis, or air trapping, including:

  • Pneumonia
  • Neuromuscular disease
  • Cystic Fibrosis
  • Inhalation injury
  • Acute respiratory distress syndrome
  • COPD
  • Post-surgical
  • Asthma
  • Bronchiolitis
  • Respiratory syncytial virus

Adaptable delivery methods and devices support care from home-based prevention to critical care secretion management and can be delivered via:

Mouthpiece

Instruct patient to keep lips and cheeks tight to ensure the pulses are directed into the lungs.

Mask

If patient is unable to maintain seal with mouthpiece, mask delivery may be preferred.

Direct to Airway

The Phasitron can be attached directly to an artificial airway or airway adapter.

In-Line

IPV therapy can be delivered in-line with a ventilator using the In-Line Valve.

SUPPORTING PATIENTS AND PROVIDERS FROM HOSPITAL TO HOME

Sentec IPV® Therapy Devices

Sentec IPV® Therapy devices continue the legacy of safe, versatile, and effective IPV® therapy, established by Percussionaire, leveraging the unique efficacy of the Phasitron for patients with a variety of respiratory conditions. A range of IPV® therapy devices feature customizable settings, allowing healthcare providers to tailor treatment for patient comfort and treatment goals.

*Not all products are available in all geographies. Contact us to learn what IPV® therapy solutions are available in your area or get support for your legacy device.

IPV® 1

Offers a simplified clinical experience for patients and providers.

IPV® -2C

Enhances the clinical versatility of IPV therapy with additional treatment-tailoring options.

IMPULSATOR

Allows the therapeutic benefits of IPV therapy to be delivered at home.

References

  1. Conomon, D., et al. Respiratory Care. 2021.
  2. Deakins, K., et al. Respiratory Care. 2002.
  3. Vargas, F., et al. Critical Care. 2005. 

Still have questions?

Complete this form for additional product support. After you’ve submitted your query, the appropriate Sentec associate will reach out with more information.